H-Gly-Gly-Cys-OH
Modify Date: 2024-01-14 16:50:04
H-Gly-Gly-Cys-OH structure
|
Common Name | H-Gly-Gly-Cys-OH | ||
|---|---|---|---|---|
| CAS Number | 95416-30-1 | Molecular Weight | 235.26 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C7H13N3O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of H-Gly-Gly-Cys-OHGlycylglycylcysteine is a Thrombin Activatable Fibrinolysis Inhibitor (TAFI) inhibitor with a Ki of 0.99 μM and a IC50 of 9.4 μM in TAFI substrate assays. TAFI is a basic carboxypeptidase that functions as a fibrinolysis inhibitor through the cleavage of C-terminal lysine on partially degraded fibrin[1]. |
| Name | (2R)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-sulfanylpropanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Glycylglycylcysteine is a Thrombin Activatable Fibrinolysis Inhibitor (TAFI) inhibitor with a Ki of 0.99 μM and a IC50 of 9.4 μM in TAFI substrate assays. TAFI is a basic carboxypeptidase that functions as a fibrinolysis inhibitor through the cleavage of C-terminal lysine on partially degraded fibrin[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 9.4 μM (TAFI) Ki: 0.99 μM (TAFI)[1] |
| References |
| Molecular Formula | C7H13N3O4S |
|---|---|
| Molecular Weight | 235.26 |
| Exact Mass | 235.06300 |
| PSA | 167.30000 |
| Glycyl-glycyl-cysteine |
| Gly-gly-cys |